DE3382837D1 - Herstellung von funktionellen, menschlichen Urokinaseproteinen - Google Patents

Herstellung von funktionellen, menschlichen Urokinaseproteinen

Info

Publication number
DE3382837D1
DE3382837D1 DE3382837T DE3382837T DE3382837D1 DE 3382837 D1 DE3382837 D1 DE 3382837D1 DE 3382837 T DE3382837 T DE 3382837T DE 3382837 T DE3382837 T DE 3382837T DE 3382837 D1 DE3382837 D1 DE 3382837D1
Authority
DE
Germany
Prior art keywords
production
functional human
human urokinase
proteins
urokinase proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3382837T
Other languages
English (en)
Other versions
DE3382837T2 (de
Inventor
Herbert Louis Heyneker
William Evans Holmes
Gordon Alan Vehar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE3382837D1 publication Critical patent/DE3382837D1/de
Anticipated expiration legal-status Critical
Publication of DE3382837T2 publication Critical patent/DE3382837T2/de
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DE3382837T 1982-04-15 1983-04-14 Herstellung von funktionellen, menschlichen Urokinaseproteinen Expired - Lifetime DE3382837T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36877382A 1982-04-15 1982-04-15
US47493083A 1983-03-14 1983-03-14

Publications (2)

Publication Number Publication Date
DE3382837D1 true DE3382837D1 (de) 2003-03-13
DE3382837T2 DE3382837T2 (de) 2004-01-15

Family

ID=27004326

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3382837T Expired - Lifetime DE3382837T2 (de) 1982-04-15 1983-04-14 Herstellung von funktionellen, menschlichen Urokinaseproteinen
DE3382760T Expired - Lifetime DE3382760T2 (de) 1982-04-15 1983-04-14 Herstellung von funktionellen menschlichen Urokinasepolypeptiden.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3382760T Expired - Lifetime DE3382760T2 (de) 1982-04-15 1983-04-14 Herstellung von funktionellen menschlichen Urokinasepolypeptiden.

Country Status (20)

Country Link
EP (2) EP0092182B1 (de)
JP (3) JPH0655145B2 (de)
AT (2) ATE232237T1 (de)
AU (1) AU573523B2 (de)
BR (1) BR8301918A (de)
CA (1) CA1341301C (de)
DE (2) DE3382837T2 (de)
DK (1) DK173910B1 (de)
ES (3) ES521418A0 (de)
FI (1) FI88932C (de)
GR (1) GR78180B (de)
HK (1) HK38297A (de)
IE (1) IE64536B1 (de)
IL (2) IL68366A (de)
MY (1) MY102472A (de)
NO (1) NO831317L (de)
NZ (1) NZ203869A (de)
PH (4) PH24783A (de)
PT (1) PT76546B (de)
YU (1) YU45128B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
AU587960B2 (en) * 1983-06-24 1989-09-07 Genentech Inc. Procaryotic carbonyl hydrolases
NZ208612A (en) * 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
DE3486023T2 (de) * 1983-09-13 1993-06-24 Green Cross Corp Verfahren zur herstellung von urokinase zymogen.
JPS60180591A (ja) * 1984-02-27 1985-09-14 Green Cross Corp:The ヒトウロキナ−ゼのｄνａ配列，プラスミド，宿主
JPS61177987A (ja) * 1985-01-31 1986-08-09 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
DE3585097D1 (de) * 1984-02-27 1992-02-20 Green Cross Corp Herstellung menschlicher urokinase.
JPS61181377A (ja) * 1985-01-25 1986-08-14 Sagami Chem Res Center ヒトウロキナ−ゼ遺伝子
DE3680838D1 (de) * 1985-01-25 1991-09-19 Sagami Chem Res Stabilisierte menschliche prourokinase.
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
US4997766A (en) * 1986-07-11 1991-03-05 American Home Products Corporation Poly-kringle plasminogen activator
US4916071A (en) 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
JPS62149625A (ja) * 1985-12-25 1987-07-03 Green Cross Corp:The 生理活性物質の製造方法
DE3613401A1 (de) * 1986-04-21 1987-12-17 Boehringer Mannheim Gmbh Verfahren zur herstellung von plasminogen-aktivatoren in prokaryonten
NL8601240A (nl) * 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
GB8623823D0 (en) * 1986-10-03 1986-11-05 Sandoz Ltd Therapeutic lysis of fibrin blood clots
JPS63105675A (ja) * 1986-10-23 1988-05-10 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
IE880255L (en) * 1987-01-30 1988-07-30 American Home Prod Des-epidermal growth factor activators.
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
DE3886517T2 (de) * 1987-08-19 1994-04-21 Central Glass Co Ltd Menschlicher Prourokinase ähnliches Polypeptid.
JP2730923B2 (ja) * 1987-10-02 1998-03-25 ザイモジェネティクス，インコーポレイティド Ｂａｒ１分泌シグナル
EP0316068A1 (de) * 1987-10-09 1989-05-17 Collaborative Research Inc. Modifizierter Plasminogenaktivator mit niedrigem Molekulargewicht und Verfahren zu seiner Herstellung
US4999194A (en) * 1988-01-14 1991-03-12 Collaborative Research, Inc. Two-chain urokinase plasminogen activators for treatment of thrombotic disease
US4920051A (en) * 1988-02-03 1990-04-24 Damon Biotech, Inc. Recovery of urokinase compounds
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
EP0897987B1 (de) * 1989-10-24 2001-02-28 Chiron Corporation Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein
DE4101736A1 (de) * 1991-01-22 1992-07-23 Gruenenthal Gmbh Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
JP2003525578A (ja) * 1998-06-26 2003-09-02 クロプテック・デヴェロップメント・コーポレイション 植物ベースの発現システムにおけるウロキナーゼの製造
WO2001097752A2 (en) * 2000-06-20 2001-12-27 The Trustees Of The University Of Pennsylvania Compositions comprising urokinase for modulating muscle contractility and angiogenisis
KR101691692B1 (ko) * 2005-10-21 2016-12-30 카탈리스트 바이오사이언시즈, 인코포레이티드 보체 활성화를 억제하는 변형된 프로테아제
NZ596269A (en) 2006-07-05 2012-12-21 Catalyst Biosciences Inc Protease screening methods and proteases identified thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1382A (en) * 1979-11-13 1987-12-18 Syed Shaukat Husain Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4321363A (en) * 1980-02-21 1982-03-23 Nippon Soda Company Limited Adsorbent for urokinase containing agarose
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
DE3479520D1 (en) * 1983-11-21 1989-09-28 Ciba Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast

Also Published As

Publication number Publication date
IL83236A0 (en) 1987-12-31
EP0092182A2 (de) 1983-10-26
FI831228A0 (fi) 1983-04-12
JPH0530970A (ja) 1993-02-09
JPH0655145B2 (ja) 1994-07-27
DK163683D0 (da) 1983-04-14
NZ203869A (en) 1987-04-30
PH24783A (en) 1990-10-30
JPH0824579B2 (ja) 1996-03-13
NO831317L (no) 1983-10-17
EP0620279A1 (de) 1994-10-19
DE3382837T2 (de) 2004-01-15
ES8500325A1 (es) 1984-11-01
IE830850L (en) 1983-10-15
HK38297A (en) 1997-04-04
PT76546A (en) 1983-05-01
CA1341301C (en) 2001-10-09
JP2584192B2 (ja) 1997-02-19
FI88932B (fi) 1993-04-15
DE3382760D1 (de) 1994-11-17
JPH07186A (ja) 1995-01-06
YU45128B (en) 1992-03-10
IL68366A0 (en) 1983-07-31
MY102472A (en) 1992-06-30
DE3382760T2 (de) 1995-03-02
GR78180B (de) 1984-09-26
EP0092182B1 (de) 1994-10-12
ES533924A0 (es) 1985-07-01
DK173910B1 (da) 2002-02-11
AU573523B2 (en) 1988-06-16
FI831228L (fi) 1983-10-16
IE950235L (en) 1983-10-15
ES521418A0 (es) 1984-11-01
DK163683A (da) 1983-11-28
AU1352483A (en) 1983-10-20
PT76546B (en) 1986-03-20
ES8602121A1 (es) 1985-12-01
PH22461A (en) 1988-09-12
FI88932C (fi) 1993-07-26
YU86883A (en) 1988-10-31
PH25312A (en) 1991-04-30
PH25120A (en) 1991-02-19
ES533925A0 (es) 1985-12-01
IE64536B1 (en) 1995-08-09
JPS5951300A (ja) 1984-03-24
EP0620279B1 (de) 2003-02-05
IL68366A (en) 1990-08-31
BR8301918A (pt) 1983-12-20
ATE112802T1 (de) 1994-10-15
ES8506087A1 (es) 1985-07-01
EP0092182A3 (en) 1984-07-18
ATE232237T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
DK371087A (da) Mamalialt interleukin-4
ATE91714T1 (de) Transformation von trichoderma.
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
MX168507B (es) Procedimiento para la produccion de proteinas
DK260188A (da) Enzymproduktion
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.
ATE83800T1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition